| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Hyperion Defi, Inc. (HYPD) has 7 insiders with recent SEC Form 4 filings, including 23 buys and 0 sells. HYPD is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 1.39M | $5.14M | +8.0K | |
| CFO | 327.9K | $1.22M | - | |
| Dir | 111.9K | $415.3K | - | |
| Dir | 88.0K | $326.5K | - | |
| Other | 75.0K | $278.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 24, 2020 | Mario Ernest | Director | Buy | 82,431 | $2.27 | $187,118.37 | +33.7% | |
| Mar 23, 2020 | Grant Stuart M. | 10% Owner | Buy | 903,240 | $2.06 | $1,858,867.92 | +38.3% | |
| Nov 13, 2019 | Grant Stuart M. | 10% Owner | Buy | 131,017 | $3.03 | $397,172.45 | +0.5% | |
| Sep 30, 2019 | Rowe Michael M | Vice President, Commercial | Buy | 100 | $3.84 | $384.00 | +7.7% | |
| Jul 11, 2019 | Mario Ernest | Director | Buy | 35,971 | $2.78 | $99,999.38 | +15.2% | |
| Jul 11, 2019 | Labelle Curt H | Director | Buy | 17,985 | $2.78 | $49,998.30 | +179.8% | |
| Jul 11, 2019 | Ianchulev Tsontcho77 | Chief Executive Officer | Buy | 233,813 | $2.78 | $650,000.14 | +121.5% | |
| Sep 25, 2018 | Rowe Michael M | Vice President Of Marketing | Buy | 800 | $4.23 | $3,380.00 | +133.3% | |
| Sep 19, 2018 | Mather Charles E IV | Director | Buy | 4,000 | $4.79 | $19,140.00 | +44.1% | |
| Jun 28, 2018 | Gandolfo John P | Chief Financial Officer | Buy | 2,000 | $5.86 | $11,720.00 | New |